GENinCode Past Earnings Performance
Past criteria checks 0/6
GENinCode's earnings have been declining at an average annual rate of -36.8%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 30.5% per year.
Key information
-36.8%
Earnings growth rate
28.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 30.5% |
| Return on equity | -211.2% |
| Net Margin | -228.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How GENinCode makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 3 | -6 | 7 | 0 |
| 31 Mar 24 | 2 | -6 | 7 | 0 |
| 31 Dec 23 | 2 | -7 | 8 | 0 |
| 30 Sep 23 | 2 | -7 | 8 | 0 |
| 30 Jun 23 | 2 | -7 | 8 | 0 |
| 31 Mar 23 | 2 | -6 | 7 | 0 |
| 31 Dec 22 | 1 | -6 | 6 | 0 |
| 30 Sep 22 | 1 | -6 | 6 | 0 |
| 30 Jun 22 | 1 | -5 | 5 | 0 |
| 31 Mar 22 | 1 | -5 | 5 | 0 |
| 31 Dec 21 | 1 | -4 | 4 | 0 |
| 30 Sep 21 | 1 | -3 | 3 | 0 |
| 30 Jun 21 | 1 | -2 | 2 | 0 |
| 31 Mar 21 | 1 | -1 | 2 | 0 |
| 31 Dec 20 | 1 | -1 | 2 | 0 |
| 31 Dec 19 | 1 | 0 | 1 | 0 |
Quality Earnings: 9PL is currently unprofitable.
Growing Profit Margin: 9PL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9PL is unprofitable, and losses have increased over the past 5 years at a rate of 36.8% per year.
Accelerating Growth: Unable to compare 9PL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9PL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: 9PL has a negative Return on Equity (-211.23%), as it is currently unprofitable.